Compounding pharmacies can resume making tirzepatide as FDA reconsiders shortage

3 days ago 4

The FDA said in a court filing late Friday that it would allow pharmacists to continue making compounded versions of tirzepatide as it reconsiders whether the drug is in shortage.

Read Entire Article

Compounding pharmacies can resume making tirzepatide as FDA reconsiders shortage

Related

Trump overcharged Secret Service agents to stay at his D.C. ...

Democrats catch up on election enthusiasm, but two key group...

Trump family gets 75% of crypto coin revenue, has no liabili...

NFL stadiums could experience $11 billion in climate-related...

Trending

Popular

Four key takeaways from Huw Edwards' sentencing

Loch Lomond Flamingo Land resort rejected by park authority

Diane Abbott: Starmer treated me as a 'non person'

Facebook owner bans Russian state media networks

Jane's Addiction cancel tour after on-stage brawl

Floods and mudslides kill more than 200 in Myanmar

'All good here': Titan sub crew's last words before implosio...

TikTok says US ban would have 'staggering' impact on users' ...

Russia is 'going backwards' in equipment and deploying post ...

Chiles appeals to Supreme Court over Olympic bronze